BioNTech SE (BNTX) Short term Debt (2018 - 2024)

BioNTech SE (BNTX) has 7 years of Short term Debt data on file, last reported at $1.5 billion in Q4 2024.

• For the quarter ending Q4 2024, Short term Debt rose 245.27% year-over-year to $1.5 billion; the trailing twelve-month figure through Dec 2024 stood at $1.5 billion (up 245.27% YoY), and the FY2024 full-year result was $1.5 billion, up 245.27% from the prior year.
• Short term Debt climbed to $1.5 billion in Q4 2024, from $446.7 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $1.7 billion in Q4 2021 to a low of $40.1 million in Q1 2023.
• A 5-year average of $768.7 million and a median of $623.9 million in 2022 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt surged 1816.75% in 2021 and plunged 52.7% in 2022, its largest moves.
• Tracing BNTX's Short term Debt over 5 years: stood at $88.3 million in 2020, then surged by 1816.75% to $1.7 billion in 2021, then plunged by 52.7% to $801.0 million in 2022, then sank by 44.23% to $446.7 million in 2023, then surged by 245.27% to $1.5 billion in 2024.
• Business Quant data shows BNTX's Short term Debt at $1.5 billion in Q4 2024, $446.7 million in Q4 2023, and $40.1 million in Q1 2023.